Bayer AG

Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs's next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs has 2.55B shares outstanding.

As of June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs posted a negative return on equity (ROE) of -5.80, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.64, reflecting losses generated across the asset base. The company generates approximately 861.55M in revenue per employee across its workforce of 89,262.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.54 indicates how many times Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs recorded 830.48B in income tax expense. The company reported a pretax loss of -2.07T and -2.95T in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 14, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs's stock has gained approximately 676.32% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs generated 76.90T in revenue and converted that into -2.95T in net income, yielding earnings per share of -1,096.24. EBITDA reached 20.18T, while operating income came in at 13.82T.

These figures are as of June 30, 2026. Total book value stands at 50.14T, with working capital of 2.33T providing operational flexibility.

Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs produced 8.11T in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.58T in capital expenditures, free cash flow totaled 3.52T - equivalent to 1,329.82 per share.

Over the twelve months ended June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs posted a gross margin of 59.05, reflecting its pricing power and cost economics. The operating margin of 17.98 and net profit margin of -3.83 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs paid dividends of 83.83 per share. The dividend payout ratio of -7.76 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Bayer AG ADR Cert Deposito Arg Repr 0.333333 Shs's most recent stock split took place on October 22, 2020 with a 1:3 split ratio.